Global Melanoma Skin Cancer Diagnostic Testing Market Insights, Forecast to 2029
This report presents an overview of global market for Melanoma Skin Cancer Diagnostic Testing market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Melanoma Skin Cancer Diagnostic Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Melanoma Skin Cancer Diagnostic Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Melanoma Skin Cancer Diagnostic Testing revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Melanoma Skin Cancer Diagnostic Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Melanoma Skin Cancer Diagnostic Testing revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Myriad Genetics, Abbott Laboratories, Foundation Medicine, Pathway Genomics Corporation, Cancer Genetics, Castle Biosciences, NeoGenomics, Dermtech and Sysmex Inostics, etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Melanoma Skin Cancer Diagnostic Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Melanoma Skin Cancer Diagnostic Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Melanoma Skin Cancer Diagnostic Testing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
This report researches the key producers of Melanoma Skin Cancer Diagnostic Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Melanoma Skin Cancer Diagnostic Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Melanoma Skin Cancer Diagnostic Testing revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Melanoma Skin Cancer Diagnostic Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Melanoma Skin Cancer Diagnostic Testing revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Myriad Genetics, Abbott Laboratories, Foundation Medicine, Pathway Genomics Corporation, Cancer Genetics, Castle Biosciences, NeoGenomics, Dermtech and Sysmex Inostics, etc.
By Company
- Myriad Genetics
- Abbott Laboratories
- Foundation Medicine
- Pathway Genomics Corporation
- Cancer Genetics
- Castle Biosciences
- NeoGenomics
- Dermtech
- Sysmex Inostics
- Biopsy
- Imaging
- Others
- Hospitals
- Dermatology Clinics
- Diagnostic Laboratories
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East, Africa, and Latin America
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Melanoma Skin Cancer Diagnostic Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Melanoma Skin Cancer Diagnostic Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Melanoma Skin Cancer Diagnostic Testing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Melanoma Skin Cancer Diagnostic Testing Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Biopsy
1.2.3 Imaging
1.2.4 Others
1.3 Market by Application
1.3.1 Global Melanoma Skin Cancer Diagnostic Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Dermatology Clinics
1.3.4 Diagnostic Laboratories
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Melanoma Skin Cancer Diagnostic Testing Market Perspective (2018-2029)
2.2 Global Melanoma Skin Cancer Diagnostic Testing Growth Trends by Region
2.2.1 Melanoma Skin Cancer Diagnostic Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Melanoma Skin Cancer Diagnostic Testing Historic Market Size by Region (2018-2023)
2.2.3 Melanoma Skin Cancer Diagnostic Testing Forecasted Market Size by Region (2024-2029)
2.3 Melanoma Skin Cancer Diagnostic Testing Market Dynamics
2.3.1 Melanoma Skin Cancer Diagnostic Testing Industry Trends
2.3.2 Melanoma Skin Cancer Diagnostic Testing Market Drivers
2.3.3 Melanoma Skin Cancer Diagnostic Testing Market Challenges
2.3.4 Melanoma Skin Cancer Diagnostic Testing Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Melanoma Skin Cancer Diagnostic Testing by Players
3.1.1 Global Melanoma Skin Cancer Diagnostic Testing Revenue by Players (2018-2023)
3.1.2 Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Players (2018-2023)
3.2 Global Melanoma Skin Cancer Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Melanoma Skin Cancer Diagnostic Testing, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Melanoma Skin Cancer Diagnostic Testing Market Concentration Ratio
3.4.1 Global Melanoma Skin Cancer Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Melanoma Skin Cancer Diagnostic Testing Revenue in 2022
3.5 Global Key Players of Melanoma Skin Cancer Diagnostic Testing Head office and Area Served
3.6 Global Key Players of Melanoma Skin Cancer Diagnostic Testing, Product and Application
3.7 Global Key Players of Melanoma Skin Cancer Diagnostic Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 MELANOMA SKIN CANCER DIAGNOSTIC TESTING BREAKDOWN DATA BY TYPE
4.1 Global Melanoma Skin Cancer Diagnostic Testing Historic Market Size by Type (2018-2023)
4.2 Global Melanoma Skin Cancer Diagnostic Testing Forecasted Market Size by Type (2024-2029)
5 MELANOMA SKIN CANCER DIAGNOSTIC TESTING BREAKDOWN DATA BY APPLICATION
5.1 Global Melanoma Skin Cancer Diagnostic Testing Historic Market Size by Application (2018-2023)
5.2 Global Melanoma Skin Cancer Diagnostic Testing Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Melanoma Skin Cancer Diagnostic Testing Market Size (2018-2029)
6.2 North America Melanoma Skin Cancer Diagnostic Testing Market Size by Type
6.2.1 North America Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2018-2023)
6.2.2 North America Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2024-2029)
6.2.3 North America Melanoma Skin Cancer Diagnostic Testing Market Share by Type (2018-2029)
6.3 North America Melanoma Skin Cancer Diagnostic Testing Market Size by Application
6.3.1 North America Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2018-2023)
6.3.2 North America Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2024-2029)
6.3.3 North America Melanoma Skin Cancer Diagnostic Testing Market Share by Application (2018-2029)
6.4 North America Melanoma Skin Cancer Diagnostic Testing Market Size by Country
6.4.1 North America Melanoma Skin Cancer Diagnostic Testing Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2018-2023)
6.4.3 North America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 EUROPE
7.1 Europe Melanoma Skin Cancer Diagnostic Testing Market Size (2018-2029)
7.2 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Type
7.2.1 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2018-2023)
7.2.2 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2024-2029)
7.2.3 Europe Melanoma Skin Cancer Diagnostic Testing Market Share by Type (2018-2029)
7.3 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Application
7.3.1 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2018-2023)
7.3.2 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2024-2029)
7.3.3 Europe Melanoma Skin Cancer Diagnostic Testing Market Share by Application (2018-2029)
7.4 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Country
7.4.1 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2018-2023)
7.4.3 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Melanoma Skin Cancer Diagnostic Testing Market Size (2018-2029)
8.2 China Melanoma Skin Cancer Diagnostic Testing Market Size by Type
8.2.1 China Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2018-2023)
8.2.2 China Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2024-2029)
8.2.3 China Melanoma Skin Cancer Diagnostic Testing Market Share by Type (2018-2029)
8.3 China Melanoma Skin Cancer Diagnostic Testing Market Size by Application
8.3.1 China Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2018-2023)
8.3.2 China Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2024-2029)
8.3.3 China Melanoma Skin Cancer Diagnostic Testing Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Melanoma Skin Cancer Diagnostic Testing Market Size (2018-2029)
9.2 Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Type
9.2.1 Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2018-2023)
9.2.2 Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2024-2029)
9.2.3 Asia Melanoma Skin Cancer Diagnostic Testing Market Share by Type (2018-2029)
9.3 Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Application
9.3.1 Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2018-2023)
9.3.2 Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2024-2029)
9.3.3 Asia Melanoma Skin Cancer Diagnostic Testing Market Share by Application (2018-2029)
9.4 Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Region
9.4.1 Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Region (2018-2023)
9.4.3 Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Myriad Genetics
11.1.1 Myriad Genetics Company Details
11.1.2 Myriad Genetics Business Overview
11.1.3 Myriad Genetics Melanoma Skin Cancer Diagnostic Testing Introduction
11.1.4 Myriad Genetics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023)
11.1.5 Myriad Genetics Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Melanoma Skin Cancer Diagnostic Testing Introduction
11.2.4 Abbott Laboratories Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023)
11.2.5 Abbott Laboratories Recent Developments
11.3 Foundation Medicine
11.3.1 Foundation Medicine Company Details
11.3.2 Foundation Medicine Business Overview
11.3.3 Foundation Medicine Melanoma Skin Cancer Diagnostic Testing Introduction
11.3.4 Foundation Medicine Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023)
11.3.5 Foundation Medicine Recent Developments
11.4 Pathway Genomics Corporation
11.4.1 Pathway Genomics Corporation Company Details
11.4.2 Pathway Genomics Corporation Business Overview
11.4.3 Pathway Genomics Corporation Melanoma Skin Cancer Diagnostic Testing Introduction
11.4.4 Pathway Genomics Corporation Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023)
11.4.5 Pathway Genomics Corporation Recent Developments
11.5 Cancer Genetics
11.5.1 Cancer Genetics Company Details
11.5.2 Cancer Genetics Business Overview
11.5.3 Cancer Genetics Melanoma Skin Cancer Diagnostic Testing Introduction
11.5.4 Cancer Genetics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023)
11.5.5 Cancer Genetics Recent Developments
11.6 Castle Biosciences
11.6.1 Castle Biosciences Company Details
11.6.2 Castle Biosciences Business Overview
11.6.3 Castle Biosciences Melanoma Skin Cancer Diagnostic Testing Introduction
11.6.4 Castle Biosciences Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023)
11.6.5 Castle Biosciences Recent Developments
11.7 NeoGenomics
11.7.1 NeoGenomics Company Details
11.7.2 NeoGenomics Business Overview
11.7.3 NeoGenomics Melanoma Skin Cancer Diagnostic Testing Introduction
11.7.4 NeoGenomics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023)
11.7.5 NeoGenomics Recent Developments
11.8 Dermtech
11.8.1 Dermtech Company Details
11.8.2 Dermtech Business Overview
11.8.3 Dermtech Melanoma Skin Cancer Diagnostic Testing Introduction
11.8.4 Dermtech Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023)
11.8.5 Dermtech Recent Developments
11.9 Sysmex Inostics
11.9.1 Sysmex Inostics Company Details
11.9.2 Sysmex Inostics Business Overview
11.9.3 Sysmex Inostics Melanoma Skin Cancer Diagnostic Testing Introduction
11.9.4 Sysmex Inostics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023)
11.9.5 Sysmex Inostics Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Melanoma Skin Cancer Diagnostic Testing Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Biopsy
1.2.3 Imaging
1.2.4 Others
1.3 Market by Application
1.3.1 Global Melanoma Skin Cancer Diagnostic Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Dermatology Clinics
1.3.4 Diagnostic Laboratories
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Melanoma Skin Cancer Diagnostic Testing Market Perspective (2018-2029)
2.2 Global Melanoma Skin Cancer Diagnostic Testing Growth Trends by Region
2.2.1 Melanoma Skin Cancer Diagnostic Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Melanoma Skin Cancer Diagnostic Testing Historic Market Size by Region (2018-2023)
2.2.3 Melanoma Skin Cancer Diagnostic Testing Forecasted Market Size by Region (2024-2029)
2.3 Melanoma Skin Cancer Diagnostic Testing Market Dynamics
2.3.1 Melanoma Skin Cancer Diagnostic Testing Industry Trends
2.3.2 Melanoma Skin Cancer Diagnostic Testing Market Drivers
2.3.3 Melanoma Skin Cancer Diagnostic Testing Market Challenges
2.3.4 Melanoma Skin Cancer Diagnostic Testing Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Melanoma Skin Cancer Diagnostic Testing by Players
3.1.1 Global Melanoma Skin Cancer Diagnostic Testing Revenue by Players (2018-2023)
3.1.2 Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Players (2018-2023)
3.2 Global Melanoma Skin Cancer Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Melanoma Skin Cancer Diagnostic Testing, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Melanoma Skin Cancer Diagnostic Testing Market Concentration Ratio
3.4.1 Global Melanoma Skin Cancer Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Melanoma Skin Cancer Diagnostic Testing Revenue in 2022
3.5 Global Key Players of Melanoma Skin Cancer Diagnostic Testing Head office and Area Served
3.6 Global Key Players of Melanoma Skin Cancer Diagnostic Testing, Product and Application
3.7 Global Key Players of Melanoma Skin Cancer Diagnostic Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 MELANOMA SKIN CANCER DIAGNOSTIC TESTING BREAKDOWN DATA BY TYPE
4.1 Global Melanoma Skin Cancer Diagnostic Testing Historic Market Size by Type (2018-2023)
4.2 Global Melanoma Skin Cancer Diagnostic Testing Forecasted Market Size by Type (2024-2029)
5 MELANOMA SKIN CANCER DIAGNOSTIC TESTING BREAKDOWN DATA BY APPLICATION
5.1 Global Melanoma Skin Cancer Diagnostic Testing Historic Market Size by Application (2018-2023)
5.2 Global Melanoma Skin Cancer Diagnostic Testing Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Melanoma Skin Cancer Diagnostic Testing Market Size (2018-2029)
6.2 North America Melanoma Skin Cancer Diagnostic Testing Market Size by Type
6.2.1 North America Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2018-2023)
6.2.2 North America Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2024-2029)
6.2.3 North America Melanoma Skin Cancer Diagnostic Testing Market Share by Type (2018-2029)
6.3 North America Melanoma Skin Cancer Diagnostic Testing Market Size by Application
6.3.1 North America Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2018-2023)
6.3.2 North America Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2024-2029)
6.3.3 North America Melanoma Skin Cancer Diagnostic Testing Market Share by Application (2018-2029)
6.4 North America Melanoma Skin Cancer Diagnostic Testing Market Size by Country
6.4.1 North America Melanoma Skin Cancer Diagnostic Testing Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2018-2023)
6.4.3 North America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 EUROPE
7.1 Europe Melanoma Skin Cancer Diagnostic Testing Market Size (2018-2029)
7.2 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Type
7.2.1 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2018-2023)
7.2.2 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2024-2029)
7.2.3 Europe Melanoma Skin Cancer Diagnostic Testing Market Share by Type (2018-2029)
7.3 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Application
7.3.1 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2018-2023)
7.3.2 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2024-2029)
7.3.3 Europe Melanoma Skin Cancer Diagnostic Testing Market Share by Application (2018-2029)
7.4 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Country
7.4.1 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2018-2023)
7.4.3 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Melanoma Skin Cancer Diagnostic Testing Market Size (2018-2029)
8.2 China Melanoma Skin Cancer Diagnostic Testing Market Size by Type
8.2.1 China Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2018-2023)
8.2.2 China Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2024-2029)
8.2.3 China Melanoma Skin Cancer Diagnostic Testing Market Share by Type (2018-2029)
8.3 China Melanoma Skin Cancer Diagnostic Testing Market Size by Application
8.3.1 China Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2018-2023)
8.3.2 China Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2024-2029)
8.3.3 China Melanoma Skin Cancer Diagnostic Testing Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Melanoma Skin Cancer Diagnostic Testing Market Size (2018-2029)
9.2 Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Type
9.2.1 Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2018-2023)
9.2.2 Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2024-2029)
9.2.3 Asia Melanoma Skin Cancer Diagnostic Testing Market Share by Type (2018-2029)
9.3 Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Application
9.3.1 Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2018-2023)
9.3.2 Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2024-2029)
9.3.3 Asia Melanoma Skin Cancer Diagnostic Testing Market Share by Application (2018-2029)
9.4 Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Region
9.4.1 Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Region (2018-2023)
9.4.3 Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Myriad Genetics
11.1.1 Myriad Genetics Company Details
11.1.2 Myriad Genetics Business Overview
11.1.3 Myriad Genetics Melanoma Skin Cancer Diagnostic Testing Introduction
11.1.4 Myriad Genetics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023)
11.1.5 Myriad Genetics Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Melanoma Skin Cancer Diagnostic Testing Introduction
11.2.4 Abbott Laboratories Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023)
11.2.5 Abbott Laboratories Recent Developments
11.3 Foundation Medicine
11.3.1 Foundation Medicine Company Details
11.3.2 Foundation Medicine Business Overview
11.3.3 Foundation Medicine Melanoma Skin Cancer Diagnostic Testing Introduction
11.3.4 Foundation Medicine Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023)
11.3.5 Foundation Medicine Recent Developments
11.4 Pathway Genomics Corporation
11.4.1 Pathway Genomics Corporation Company Details
11.4.2 Pathway Genomics Corporation Business Overview
11.4.3 Pathway Genomics Corporation Melanoma Skin Cancer Diagnostic Testing Introduction
11.4.4 Pathway Genomics Corporation Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023)
11.4.5 Pathway Genomics Corporation Recent Developments
11.5 Cancer Genetics
11.5.1 Cancer Genetics Company Details
11.5.2 Cancer Genetics Business Overview
11.5.3 Cancer Genetics Melanoma Skin Cancer Diagnostic Testing Introduction
11.5.4 Cancer Genetics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023)
11.5.5 Cancer Genetics Recent Developments
11.6 Castle Biosciences
11.6.1 Castle Biosciences Company Details
11.6.2 Castle Biosciences Business Overview
11.6.3 Castle Biosciences Melanoma Skin Cancer Diagnostic Testing Introduction
11.6.4 Castle Biosciences Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023)
11.6.5 Castle Biosciences Recent Developments
11.7 NeoGenomics
11.7.1 NeoGenomics Company Details
11.7.2 NeoGenomics Business Overview
11.7.3 NeoGenomics Melanoma Skin Cancer Diagnostic Testing Introduction
11.7.4 NeoGenomics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023)
11.7.5 NeoGenomics Recent Developments
11.8 Dermtech
11.8.1 Dermtech Company Details
11.8.2 Dermtech Business Overview
11.8.3 Dermtech Melanoma Skin Cancer Diagnostic Testing Introduction
11.8.4 Dermtech Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023)
11.8.5 Dermtech Recent Developments
11.9 Sysmex Inostics
11.9.1 Sysmex Inostics Company Details
11.9.2 Sysmex Inostics Business Overview
11.9.3 Sysmex Inostics Melanoma Skin Cancer Diagnostic Testing Introduction
11.9.4 Sysmex Inostics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023)
11.9.5 Sysmex Inostics Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Melanoma Skin Cancer Diagnostic Testing Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Biopsy
Table 3. Key Players of Imaging
Table 4. Key Players of Others
Table 5. Global Melanoma Skin Cancer Diagnostic Testing Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Melanoma Skin Cancer Diagnostic Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Melanoma Skin Cancer Diagnostic Testing Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Melanoma Skin Cancer Diagnostic Testing Market Share by Region (2018-2023)
Table 9. Global Melanoma Skin Cancer Diagnostic Testing Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Melanoma Skin Cancer Diagnostic Testing Market Share by Region (2024-2029)
Table 11. Melanoma Skin Cancer Diagnostic Testing Market Trends
Table 12. Melanoma Skin Cancer Diagnostic Testing Market Drivers
Table 13. Melanoma Skin Cancer Diagnostic Testing Market Challenges
Table 14. Melanoma Skin Cancer Diagnostic Testing Market Restraints
Table 15. Global Melanoma Skin Cancer Diagnostic Testing Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Melanoma Skin Cancer Diagnostic Testing Revenue Share by Players (2018-2023)
Table 17. Global Top Melanoma Skin Cancer Diagnostic Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Melanoma Skin Cancer Diagnostic Testing as of 2022)
Table 18. Global Melanoma Skin Cancer Diagnostic Testing Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Melanoma Skin Cancer Diagnostic Testing Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Melanoma Skin Cancer Diagnostic Testing, Headquarters and Area Served
Table 21. Global Key Players of Melanoma Skin Cancer Diagnostic Testing, Product and Application
Table 22. Global Key Players of Melanoma Skin Cancer Diagnostic Testing, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Type (2018-2023)
Table 26. Global Melanoma Skin Cancer Diagnostic Testing Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Type (2024-2029)
Table 28. Global Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Melanoma Skin Cancer Diagnostic Testing Revenue Share by Application (2018-2023)
Table 30. Global Melanoma Skin Cancer Diagnostic Testing Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Melanoma Skin Cancer Diagnostic Testing Revenue Share by Application (2024-2029)
Table 32. North America Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Melanoma Skin Cancer Diagnostic Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Melanoma Skin Cancer Diagnostic Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Melanoma Skin Cancer Diagnostic Testing Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2024-2029) & (US$ Million)
Table 64. Myriad Genetics Company Details
Table 65. Myriad Genetics Business Overview
Table 66. Myriad Genetics Melanoma Skin Cancer Diagnostic Testing Product
Table 67. Myriad Genetics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023) & (US$ Million)
Table 68. Myriad Genetics Recent Developments
Table 69. Abbott Laboratories Company Details
Table 70. Abbott Laboratories Business Overview
Table 71. Abbott Laboratories Melanoma Skin Cancer Diagnostic Testing Product
Table 72. Abbott Laboratories Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023) & (US$ Million)
Table 73. Abbott Laboratories Recent Developments
Table 74. Foundation Medicine Company Details
Table 75. Foundation Medicine Business Overview
Table 76. Foundation Medicine Melanoma Skin Cancer Diagnostic Testing Product
Table 77. Foundation Medicine Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023) & (US$ Million)
Table 78. Foundation Medicine Recent Developments
Table 79. Pathway Genomics Corporation Company Details
Table 80. Pathway Genomics Corporation Business Overview
Table 81. Pathway Genomics Corporation Melanoma Skin Cancer Diagnostic Testing Product
Table 82. Pathway Genomics Corporation Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023) & (US$ Million)
Table 83. Pathway Genomics Corporation Recent Developments
Table 84. Cancer Genetics Company Details
Table 85. Cancer Genetics Business Overview
Table 86. Cancer Genetics Melanoma Skin Cancer Diagnostic Testing Product
Table 87. Cancer Genetics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023) & (US$ Million)
Table 88. Cancer Genetics Recent Developments
Table 89. Castle Biosciences Company Details
Table 90. Castle Biosciences Business Overview
Table 91. Castle Biosciences Melanoma Skin Cancer Diagnostic Testing Product
Table 92. Castle Biosciences Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023) & (US$ Million)
Table 93. Castle Biosciences Recent Developments
Table 94. NeoGenomics Company Details
Table 95. NeoGenomics Business Overview
Table 96. NeoGenomics Melanoma Skin Cancer Diagnostic Testing Product
Table 97. NeoGenomics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023) & (US$ Million)
Table 98. NeoGenomics Recent Developments
Table 99. Dermtech Company Details
Table 100. Dermtech Business Overview
Table 101. Dermtech Melanoma Skin Cancer Diagnostic Testing Product
Table 102. Dermtech Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023) & (US$ Million)
Table 103. Dermtech Recent Developments
Table 104. Sysmex Inostics Company Details
Table 105. Sysmex Inostics Business Overview
Table 106. Sysmex Inostics Melanoma Skin Cancer Diagnostic Testing Product
Table 107. Sysmex Inostics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023) & (US$ Million)
Table 108. Sysmex Inostics Recent Developments
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
Table 1. Global Melanoma Skin Cancer Diagnostic Testing Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Biopsy
Table 3. Key Players of Imaging
Table 4. Key Players of Others
Table 5. Global Melanoma Skin Cancer Diagnostic Testing Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Melanoma Skin Cancer Diagnostic Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Melanoma Skin Cancer Diagnostic Testing Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Melanoma Skin Cancer Diagnostic Testing Market Share by Region (2018-2023)
Table 9. Global Melanoma Skin Cancer Diagnostic Testing Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Melanoma Skin Cancer Diagnostic Testing Market Share by Region (2024-2029)
Table 11. Melanoma Skin Cancer Diagnostic Testing Market Trends
Table 12. Melanoma Skin Cancer Diagnostic Testing Market Drivers
Table 13. Melanoma Skin Cancer Diagnostic Testing Market Challenges
Table 14. Melanoma Skin Cancer Diagnostic Testing Market Restraints
Table 15. Global Melanoma Skin Cancer Diagnostic Testing Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Melanoma Skin Cancer Diagnostic Testing Revenue Share by Players (2018-2023)
Table 17. Global Top Melanoma Skin Cancer Diagnostic Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Melanoma Skin Cancer Diagnostic Testing as of 2022)
Table 18. Global Melanoma Skin Cancer Diagnostic Testing Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Melanoma Skin Cancer Diagnostic Testing Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Melanoma Skin Cancer Diagnostic Testing, Headquarters and Area Served
Table 21. Global Key Players of Melanoma Skin Cancer Diagnostic Testing, Product and Application
Table 22. Global Key Players of Melanoma Skin Cancer Diagnostic Testing, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Type (2018-2023)
Table 26. Global Melanoma Skin Cancer Diagnostic Testing Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Type (2024-2029)
Table 28. Global Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Melanoma Skin Cancer Diagnostic Testing Revenue Share by Application (2018-2023)
Table 30. Global Melanoma Skin Cancer Diagnostic Testing Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Melanoma Skin Cancer Diagnostic Testing Revenue Share by Application (2024-2029)
Table 32. North America Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Melanoma Skin Cancer Diagnostic Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Melanoma Skin Cancer Diagnostic Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Melanoma Skin Cancer Diagnostic Testing Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Melanoma Skin Cancer Diagnostic Testing Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2024-2029) & (US$ Million)
Table 64. Myriad Genetics Company Details
Table 65. Myriad Genetics Business Overview
Table 66. Myriad Genetics Melanoma Skin Cancer Diagnostic Testing Product
Table 67. Myriad Genetics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023) & (US$ Million)
Table 68. Myriad Genetics Recent Developments
Table 69. Abbott Laboratories Company Details
Table 70. Abbott Laboratories Business Overview
Table 71. Abbott Laboratories Melanoma Skin Cancer Diagnostic Testing Product
Table 72. Abbott Laboratories Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023) & (US$ Million)
Table 73. Abbott Laboratories Recent Developments
Table 74. Foundation Medicine Company Details
Table 75. Foundation Medicine Business Overview
Table 76. Foundation Medicine Melanoma Skin Cancer Diagnostic Testing Product
Table 77. Foundation Medicine Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023) & (US$ Million)
Table 78. Foundation Medicine Recent Developments
Table 79. Pathway Genomics Corporation Company Details
Table 80. Pathway Genomics Corporation Business Overview
Table 81. Pathway Genomics Corporation Melanoma Skin Cancer Diagnostic Testing Product
Table 82. Pathway Genomics Corporation Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023) & (US$ Million)
Table 83. Pathway Genomics Corporation Recent Developments
Table 84. Cancer Genetics Company Details
Table 85. Cancer Genetics Business Overview
Table 86. Cancer Genetics Melanoma Skin Cancer Diagnostic Testing Product
Table 87. Cancer Genetics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023) & (US$ Million)
Table 88. Cancer Genetics Recent Developments
Table 89. Castle Biosciences Company Details
Table 90. Castle Biosciences Business Overview
Table 91. Castle Biosciences Melanoma Skin Cancer Diagnostic Testing Product
Table 92. Castle Biosciences Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023) & (US$ Million)
Table 93. Castle Biosciences Recent Developments
Table 94. NeoGenomics Company Details
Table 95. NeoGenomics Business Overview
Table 96. NeoGenomics Melanoma Skin Cancer Diagnostic Testing Product
Table 97. NeoGenomics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023) & (US$ Million)
Table 98. NeoGenomics Recent Developments
Table 99. Dermtech Company Details
Table 100. Dermtech Business Overview
Table 101. Dermtech Melanoma Skin Cancer Diagnostic Testing Product
Table 102. Dermtech Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023) & (US$ Million)
Table 103. Dermtech Recent Developments
Table 104. Sysmex Inostics Company Details
Table 105. Sysmex Inostics Business Overview
Table 106. Sysmex Inostics Melanoma Skin Cancer Diagnostic Testing Product
Table 107. Sysmex Inostics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023) & (US$ Million)
Table 108. Sysmex Inostics Recent Developments
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Melanoma Skin Cancer Diagnostic Testing Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Melanoma Skin Cancer Diagnostic Testing Market Share by Type: 2022 VS 2029
Figure 3. Biopsy Features
Figure 4. Imaging Features
Figure 5. Others Features
Figure 6. Global Melanoma Skin Cancer Diagnostic Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Melanoma Skin Cancer Diagnostic Testing Market Share by Application: 2022 VS 2029
Figure 8. Hospitals Case Studies
Figure 9. Dermatology Clinics Case Studies
Figure 10. Diagnostic Laboratories Case Studies
Figure 11. Others Case Studies
Figure 12. Melanoma Skin Cancer Diagnostic Testing Report Years Considered
Figure 13. Global Melanoma Skin Cancer Diagnostic Testing Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Melanoma Skin Cancer Diagnostic Testing Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Melanoma Skin Cancer Diagnostic Testing Market Share by Region: 2022 VS 2029
Figure 16. Global Melanoma Skin Cancer Diagnostic Testing Market Share by Players in 2022
Figure 17. Global Top Melanoma Skin Cancer Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Melanoma Skin Cancer Diagnostic Testing as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Melanoma Skin Cancer Diagnostic Testing Revenue in 2022
Figure 19. North America Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Melanoma Skin Cancer Diagnostic Testing Market Share by Type (2018-2029)
Figure 21. North America Melanoma Skin Cancer Diagnostic Testing Market Share by Application (2018-2029)
Figure 22. North America Melanoma Skin Cancer Diagnostic Testing Market Share by Country (2018-2029)
Figure 23. United States Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Melanoma Skin Cancer Diagnostic Testing Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe Melanoma Skin Cancer Diagnostic Testing Market Share by Type (2018-2029)
Figure 27. Europe Melanoma Skin Cancer Diagnostic Testing Market Share by Application (2018-2029)
Figure 28. Europe Melanoma Skin Cancer Diagnostic Testing Market Share by Country (2018-2029)
Figure 29. Germany Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China Melanoma Skin Cancer Diagnostic Testing Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China Melanoma Skin Cancer Diagnostic Testing Market Share by Type (2018-2029)
Figure 37. China Melanoma Skin Cancer Diagnostic Testing Market Share by Application (2018-2029)
Figure 38. Asia Melanoma Skin Cancer Diagnostic Testing Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia Melanoma Skin Cancer Diagnostic Testing Market Share by Type (2018-2029)
Figure 40. Asia Melanoma Skin Cancer Diagnostic Testing Market Share by Application (2018-2029)
Figure 41. Asia Melanoma Skin Cancer Diagnostic Testing Market Share by Region (2018-2029)
Figure 42. Japan Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Share by Country (2018-2029)
Figure 52. Brazil Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Myriad Genetics Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023)
Figure 59. Abbott Laboratories Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023)
Figure 60. Foundation Medicine Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023)
Figure 61. Pathway Genomics Corporation Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023)
Figure 62. Cancer Genetics Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023)
Figure 63. Castle Biosciences Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023)
Figure 64. NeoGenomics Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023)
Figure 65. Dermtech Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023)
Figure 66. Sysmex Inostics Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Figure 1. Global Melanoma Skin Cancer Diagnostic Testing Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Melanoma Skin Cancer Diagnostic Testing Market Share by Type: 2022 VS 2029
Figure 3. Biopsy Features
Figure 4. Imaging Features
Figure 5. Others Features
Figure 6. Global Melanoma Skin Cancer Diagnostic Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Melanoma Skin Cancer Diagnostic Testing Market Share by Application: 2022 VS 2029
Figure 8. Hospitals Case Studies
Figure 9. Dermatology Clinics Case Studies
Figure 10. Diagnostic Laboratories Case Studies
Figure 11. Others Case Studies
Figure 12. Melanoma Skin Cancer Diagnostic Testing Report Years Considered
Figure 13. Global Melanoma Skin Cancer Diagnostic Testing Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Melanoma Skin Cancer Diagnostic Testing Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Melanoma Skin Cancer Diagnostic Testing Market Share by Region: 2022 VS 2029
Figure 16. Global Melanoma Skin Cancer Diagnostic Testing Market Share by Players in 2022
Figure 17. Global Top Melanoma Skin Cancer Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Melanoma Skin Cancer Diagnostic Testing as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Melanoma Skin Cancer Diagnostic Testing Revenue in 2022
Figure 19. North America Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Melanoma Skin Cancer Diagnostic Testing Market Share by Type (2018-2029)
Figure 21. North America Melanoma Skin Cancer Diagnostic Testing Market Share by Application (2018-2029)
Figure 22. North America Melanoma Skin Cancer Diagnostic Testing Market Share by Country (2018-2029)
Figure 23. United States Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Melanoma Skin Cancer Diagnostic Testing Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe Melanoma Skin Cancer Diagnostic Testing Market Share by Type (2018-2029)
Figure 27. Europe Melanoma Skin Cancer Diagnostic Testing Market Share by Application (2018-2029)
Figure 28. Europe Melanoma Skin Cancer Diagnostic Testing Market Share by Country (2018-2029)
Figure 29. Germany Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China Melanoma Skin Cancer Diagnostic Testing Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China Melanoma Skin Cancer Diagnostic Testing Market Share by Type (2018-2029)
Figure 37. China Melanoma Skin Cancer Diagnostic Testing Market Share by Application (2018-2029)
Figure 38. Asia Melanoma Skin Cancer Diagnostic Testing Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia Melanoma Skin Cancer Diagnostic Testing Market Share by Type (2018-2029)
Figure 40. Asia Melanoma Skin Cancer Diagnostic Testing Market Share by Application (2018-2029)
Figure 41. Asia Melanoma Skin Cancer Diagnostic Testing Market Share by Region (2018-2029)
Figure 42. Japan Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America Melanoma Skin Cancer Diagnostic Testing Market Share by Country (2018-2029)
Figure 52. Brazil Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Myriad Genetics Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023)
Figure 59. Abbott Laboratories Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023)
Figure 60. Foundation Medicine Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023)
Figure 61. Pathway Genomics Corporation Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023)
Figure 62. Cancer Genetics Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023)
Figure 63. Castle Biosciences Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023)
Figure 64. NeoGenomics Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023)
Figure 65. Dermtech Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023)
Figure 66. Sysmex Inostics Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2018-2023)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
